In other countries
The same active substances on other registers, the same brand first.
- Rebif 22 Microgramos/0,5 ML Solucion Inyectable en CartuchoSpain · 22 µg · solución inyectable en cartucho · Merck Europe B.V.Same brand
- REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHOSpain · 44 µg · solución inyectable en cartucho · Merck Europe B.V.Same brand
- Rebif 44 Microgramos/0,5 ML Solucion Inyectable en CartuchoSpain · 44 µg · solución inyectable en cartucho · Merck Europe B.V.Same brand
- RebifEuropean Union · Merck Europe B.V.Same brand
- RebifCroatiaSame brand
- RebifItaly · Soluzione iniettabile · Merck Europe B.V.Same brand
- Rebif 22 microgram/0,5ml, oplossing voor injectie in een patroonNetherlands · Oplossing voor injectie · Merck Europe B.V.Same brand
- Rebif 22 microgram, oplossing voor injectieNetherlands · Oplossing voor injectie · Merck Europe B.V.Same brand
- Rebif 44 microgram/0,5ml, oplossing voor injectie in een patroonNetherlands · Oplossing voor injectie · Merck Europe B.V.Same brand
- REBIF 44 microgrameRomania · 44µg · sol. inj. in seringa preumpluta · Merck Europe B.V.Same brand
- REBIF 44 microgrameRomania · 44mcg · sol. inj. in seringa preumpluta · Merck Serono Europe LTDSame brand
- REBIF 44 micrograme/0.5 mlRomania · 44micrograme/0,5ml · sol inj. in cartus · Merck Europe B.V.Same brand
- Rebif®Serbia · 22mcg/0.5mL · rastvor za injekciju u ulošku · Merck D.O.O. BeogradSame brand
- Rebif®Serbia · 44mcg/0.5mL · rastvor za injekciju u ulošku · Merck D.O.O. BeogradSame brand
- Rebif®Serbia · 44mcg/ 0.5mL · rastvor za injekciju u napunjenom injekcionom špricu · Merck D.O.O. BeogradSame brand
- REBIF 22 MCG/0.5 ml Solution for injection in cartridgeSaudi Arabia · Merck Serono SPASame brand
- Rebif 22 MCG Pre-Filled SyringeSaudi Arabia · SeronoSame brand
- REBIF 44 MCG/0.5 ml Solution for injection in cartridgeSaudi Arabia · Merck Serono SPASame brand
- Rebif Solution for Injection in Cartridge 22mcg/0.5mlSingapore · 22mcg/0.5ml · injection, solution · Merck Pte. LTD.Same brand
- Rebif Solution for Injection in Cartridge 44mcg/0.5mlSingapore · 44mcg/0.5ml · injection, solution · Merck Pte. LTD.Same brand
- Rebif 22 MicrogramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same brand
- Rebif 44 MicrogramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same brand
- Rebif solution for injection 132 microgramsTaiwan · 注射劑 · 臺灣默克股份有限公司Same brand
- RebifUnited States · 8.8MCG/0.2ML · Injection · EMD Serono, Inc.Same brand
- RebifUnited States · 44MCG/0.5ML · Injection · EMD Serono, Inc.Same brand
- RebifUnited States · 8.8MCG/0.2ML · Injection · EMD Serono, Inc.Same brand
- AvonexEuropean Union · Biogen Netherlands B.V.Same substance
- BetaferonEuropean Union · Bayer AGSame substance
- AvonexCroatiaSame substance
- BetaferonCroatiaSame substance
- AvonexItaly · Soluzione iniettabile · Biogen Netherlands BVSame substance
- BetaferonItaly · Polvere e solvente per soluzione iniettabile · Bayer AGSame substance
- AnyNew Zealand · Inj 8 million iu per ml, 1 ml vialSame substance
- BetaferonNew Zealand · Inj 8 million iu per 1 mlSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Interferon beta-1a
- Strength
- 66 MCG / 1.5 ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 14 May 2009
- Registration
- DIN 02318253
- Marketing authorisation holder
- Emd Serono, A Division of Emd INC., Canada
- ATC code
- L03AB07
- Supply
- PRESCRIPTION, SCHEDULE D



